TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$149.53 USD
+0.56 (0.38%)
Updated Jul 3, 2024 01:00 PM ET
Pre-Market: $150.70 +1.17 (0.78%) 9:18 AM ET
1-Strong Buy of 5 1
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
TMDX 149.53 +0.56(0.38%)
Will TMDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMDX
TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
Are You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Trending Stock TransMedics Group, Inc. (TMDX) a Buy Now?
Will TransMedics (TMDX) Gain on Rising Earnings Estimates?
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
Other News for TMDX
What's Driving Tandem Diabetes Care Inc's Surprising 15% Stock Rally?
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), TransMedics Group (TMDX)
Critical Insights From TransMedics Gr Analyst Ratings: What You Need To Know
The 3 Best Medical Device Stocks to Buy in June 2024